NCT05730010View on ClinicalTrials.gov

Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

CompletedOBSERVATIONAL

Enrollment

289

Participants

Timeline

Start Date

April 16, 2023

Primary Completion Date

June 26, 2023

Study Completion Date

June 26, 2023

Conditions

Triple Negative Breast Cancer

Trial Locations (1)

46202

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis

All Listed Sponsors

lead

Indiana University

OTHER